HEALTH CARE WEBCAST | DEECEMBER 21, 2020 | $NTRA $TDOC + MICROQUAD UPDATE

12/18/20 02:08PM EST

MONDAY, DECEMBER 21st, 2020

Watch the replay below

Healthcare analysts Tom Tobin and William McMahon review their best stock ideas, major healthcare themes and more.

Enter your questions for Tom & Will into the chat box below.

WEEKLY POSITION MONITOR UPDATE

On Monday’s Health Care Webcast, we will cover:

  • NTRA Black Book Recap | Recap of this week's Best Idea Long presentation. Yes, its up on a rope and expensive, but it has further to run we think. Tune in next week to find out why and challenge or support our work.
  • TDOC Thesis Debate | Do we have a problem? Opinions are heated surrounding the future of telemedicine and $TDOC's role in it. We spent the week fending off the naysayers and futurists who can either overthink it, or remain steadfast and confident in their ignorance. But that's what makes a market and why this job is so hard and fun. We'll cover some of the chief complaints and our rebuttals. We'll also be hosting a call with one of those somebodies in the phrase "somebody knows something" on Tuesday. We are hoping to propagate a conversation based on questions from audience.
  • Weekly MicroQuad Update | Are we at #peakvaccine? The MicroQuad 3 bin has certainly filled up with tickers on the back side of the acceleration curve. Step carefully because there is a performance bomb with a hair trigger out there for these stocks. In MicroQuad 3, batting average and average performance lag MicroQuad 2, but they still screen long, just less so. A slightly negative news item that was ignored 3 months ago is suddenly the market's "catalyst" and the basis for a lot of storytelling about a big down move. If it bleeds it leads.

CLICK HERE to access the associated slides

https://cdn.jwplayer.com/players/B3ApniyL-x1Hp06Vr.js?sig=581296ed7e15aae741002cc4dd7876b5&exp=1608584328

© 2024 Hedgeye Risk Management, LLC. The information contained herein is the property of Hedgeye, which reserves all rights thereto. Redistribution of any part of this information is prohibited without the express written consent of Hedgeye. Hedgeye is not responsible for any errors in or omissions to this information, or for any consequences that may result from the use of this information.